Clover Health Investments, Corp. <CLOV.O>: UBS raises target price to $5 from $4.75
CLOV•Related News
Saba Capital Management buys $24,436 of New Germany Fund common shares
GF•
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition
TARS•
Armstrong’s Parallel Architectural Products wins Miami-Dade approval for HVHZ cladding boards
AWI•
Republican senators propose to repeal California emissions rules
XLY•
Nasdaq Trade Halt <AZI.O> Volatility Trading Pause at 10:08 AM
AZI•